Injectables
The latest in injectables for medical-aesthetics practice owners.
Injectables How Hyaluronidase Dissolves Filler: Mechanism, Vascular Occlusion Protocol, and Practice Liability
Hyaluronidase breaks down hyaluronic acid filler by cleaving glycosidic bonds—and knowing when to deploy it, how to manage vascular compromise, and who bears liability is essential to practice protection.
Injectables Botox Units Per Area: Standard Dosing and Practice Economics
Typical neuromodulator units by facial zone, how to price per-unit, and what drives your margin on toxin revenue.
Injectables RHA vs Juvéderm: Resilient HA and Vycross Technology Compared for Aesthetic Practice
Two distinct HA architectures—RHA's resilient polymer and Juvéderm's Vycross crosslinking—deliver different clinical profiles and longevity in dynamic facial zones.
Injectables Daxxify vs Jeuveau: Duration, Cost, and Clinical Positioning
How the extended-duration toxin and the budget neuromodulator stack up on longevity, per-treatment economics, and market positioning.
Injectables Botox vs Xeomin: Which Neuromodulator to Stock and Offer Your Patients
Both are FDA-approved botulinum toxin Type A products, but their formulations, onset profiles, dosing economics, and patient candidacy differ in ways that matter to your bottom line and clinical outcomes.
Injectables What Is a Liquid Facelift? Filler and Toxin Combination Strategy for Medspa Owners
A liquid facelift pairs neuromodulators and dermal fillers to restore volume and smooth dynamic lines—here's how to structure, price, and present it to patients.
Injectables What Is a Skin Booster? Category, Players, FDA Status, and Menu Strategy
Skin boosters are injectable hydration and biostimulation treatments positioned between skincare and fillers—with distinct regulatory pathways and revenue models for medspa operators.
Injectables Skinvive by Juvéderm: The Microdroplet HA Skin Booster for Cheek Hydration
Skinvive is a microdroplet hyaluronic acid injectable designed to hydrate and smooth cheek skin—a new category between traditional fillers and topical skincare.
Injectables What Is Rejuran? The Polynucleotide Skin Booster Reshaping the Aesthetic Market
Rejuran is a Korean-origin polynucleotide (PN) injectable that stimulates collagen and improves skin quality—but US availability remains limited despite growing practitioner and patient demand.
Injectables Letybo vs. Botox: Key Differences in Units, Onset, and Clinical Profile for Medspa Owners
Letybo and Botox are not interchangeable: they differ in potency, diffusion, onset speed, and market positioning—here's what owners need to know about unit equivalency and patient outcomes.
Injectables Is Relfydess FDA Approved? Status, Mechanism, and How It Compares to Dysport
Galderma's ready-to-use liquid botulinum toxin Type A received FDA approval in April 2024. Here's what medspa owners need to know about its formulation, clinical profile, and competitive positioning versus Dysport.
Injectables Is Evolysse FDA Approved? Evolus's HA Filler Line Explained
Evolysse is FDA-approved and represents Evolus's entry into the hyaluronic acid filler market—here's how it compares to Juvéderm and Restylane.
Injectables Sculptra vs Radiesse: Mechanism, Timeline, and Clinical Use Cases for Medspa Owners
Two FDA-cleared biostimulators with distinct mechanisms and patient outcomes—how to choose between PLLA and CaHA for your practice.
Injectables Juvéderm vs Restylane: HA Filler Families Compared by Crosslinking, Indication, and Longevity
Both HA platforms dominate the market, but their crosslinking chemistry, rheology, and clinical performance differ—here's what drives your choice and your margin.
Injectables Daxxify vs Botox: Duration, Cost, and When to Use Each
Daxxify's 6-month duration commands a premium, but Botox's 3-month cycle and lower cost make it the right choice for many practices and patients.
Injectables Botox vs Jeuveau: Which Neuromodulator to Stock and Offer
Botox dominates market share and rebate programs, but Jeuveau offers competitive unit pricing and differentiation—here's how to choose for your practice.
Injectables Botox vs Dysport: Clinical Differences, Dosing, and Economics for Injectors
How onset, diffusion, unit conversion, and cost structure differ between the two leading neuromodulators—and when to stock each.
Injectables Is Kybella FDA Approved? Current Status and What Medspa Owners Need to Know
Kybella holds full FDA clearance for submental fat reduction—here's the approval pathway, clinical evidence, and practice economics.
Injectables Is Sculptra FDA Approved? Status, Indications, and Clinical Use
Sculptra holds FDA clearance for specific facial indications and is the market-leading PLLA biostimulator—but approval scope matters for your practice.
Injectables Are RHA Fillers FDA Approved? Current Status and Clinical Use
RHA fillers hold full FDA approval for dynamic wrinkles and folds, with three products cleared under 510(k) pathways and distinct rheological profiles suited to movement-rich zones.
Injectables Is Xeomin FDA Approved? Status, Indications, and Clinical Profile
Xeomin holds full FDA approval for dynamic wrinkles and is the only "naked" botulinum toxin formulation on the U.S. market—here's what that means for your practice.
Injectables Is Skinvive by Juvéderm FDA Approved? Status, Indications, and Microdroplet Technology
Skinvive received FDA clearance in 2023 for cheek and neck skin quality—here's what the approval covers and how the microdroplet formulation works.
Injectables Is Letybo FDA Approved? Status, Mechanism, and Clinical Position
Letybo (letyrosine) received FDA approval in 2023 as a novel neuromodulator alternative to botulinum toxin for dynamic wrinkles—here's what medspa owners need to know about its regulatory path, mechanism, and market positioning.
Injectables Is Jeuveau FDA Approved? Current Status and Clinical Indications
Jeuveau holds full FDA approval for glabellar lines and is positioned as a faster-acting neuromodulator alternative to Botox and Dysport.
Injectables Is Daxxify FDA Approved? Status, Indications, and How It Compares to Botox
Daxxify received FDA approval in September 2023 as a long-acting neuromodulator with a different formulation and duration profile than Botox.
Injectables RHA Dynamic Volume Wins FDA Clearance for Midface Augmentation — New Rheology Profile Enters Market
Revance's dynamic filler gains approval for midface volume loss, offering an alternative to crosslinked HA.
Injectables Allergan Aesthetics Wins Health Canada Approval for Boey — Rapid-Onset Neuromodulator Clears Regulatory Hurdle
AbbVie's next-generation toxin candidate gains approval in Canada; U.S. pathway remains unclear.
Injectables Allergan Aesthetics Wins FDA Approval for Skinvive by Juvéderm — Neck Wrinkles Now Cleared
AbbVie's newest Juvéderm indication expands the filler portfolio into a high-volume treatment zone.
Injectables Galderma Wins FDA Approval for Restylane Contour — Temple Hollowing Now Indicated
Galderma expands its crosslinked HA portfolio into midface contouring, competing directly with volumizers.
Get the free weekly brief.
The week's most important moves in medical aesthetics — distilled to a two-minute read, free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.